Safety and Efficacy of FSD201 for the Treatment of Chronic Pain Associated With Idiopathic MCAS (MCAD)
Trial details
- Registry ID
- NCT05652907
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Safety and Efficacy of FSD201 for the Treatment of Chronic Pain Associated With Idiopathic MCAS (MCAD)NCT05652907 | Quantum Biopharma | Phase 2 | Terminated | 2023-05-24Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |